TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
Recruiting · NCT06051253 · Registry updated 2024-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Phase 4 | 2024-05-14 | NCT06051253 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Asan Medical Center | 114 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 338 |